Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Merk

Showing results (61-70 of 165) with videos related to

Pageof 17
Sort By:
ACS Medicinal Chemistry Letters|January 8, 2026
Dual Nurr1/RXR agonism of valerenic acid and synthetic mimetics enables dimer-selective Nurr1 modulationKatharina Scholz, Úrsula López-García, Romy Busch, et al.
Nature Communications|April 11, 2026
Structural optimization of drug molecules with incrementally trained language modelsTim Hörmann, Domenic Mayer, Max Lewandowski, et al.
Biochemical Pharmacology|May 27, 2019
A dual farnesoid X receptor/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in miceMd Abdul Hye Khan, Jurema Schmidt, Anna Stavniichuk, et al.
Journal of Medicinal Chemistry|October 23, 2025
Scaffold Fusion and SAR Transfer with a Chemical Language Model Generates Novel Liver X Receptor ModulatorsNils Christiaan Bandomir, Tim Hörmann, Annette Kärcher, et al.
Future Medicinal Chemistry|January 30, 2016
SAR studies on FXR modulators led to the discovery of the first combined FXR antagonistic/TGR5 agonistic compoundChristina Lamers, Daniel Merk, Matthias Gabler, et al.
International Journal of Molecular Sciences|September 9, 2022
Activity Screening of Fatty Acid Mimetic Drugs Identified Nuclear Receptor AgonistsMoritz Helmstädter, Simone Schierle, Laura Isigkeit, et al.
Frontiers in Immunology|January 18, 2024
Dual soluble epoxide hydrolase inhibitor - farnesoid X receptor agonist interventional treatment attenuates renal inflammation and fibrosisMd Abdul Hye Khan, Benjamin Nolan, Anna Stavniichuk, et al.
Communications Chemistry|January 27, 2023
The orphan nuclear receptor Nurr1 is responsive to non-steroidal anti-inflammatory drugsSabine Willems, Whitney Kilu, Xiaomin Ni, et al.
Journal of Medicinal Chemistry|July 21, 2020
Design and Structural Optimization of Dual FXR/PPARδ ActivatorsSimone Schierle, Sebastian Neumann, Pascal Heitel, et al.
International Journal of Molecular Sciences|November 14, 2020
Comprehensive Set of Tertiary Complex Structures and Palmitic Acid Binding Provide Molecular Insights into Ligand Design for RXR IsoformsApirat Chaikuad, Julius Pollinger, Michael Rühl, et al.
Pageof 17

Showing results (61-70 of 165) with videos related to

Sort By:
Pageof 17
ACS Medicinal Chemistry Letters|January 8, 2026
Dual Nurr1/RXR agonism of valerenic acid and synthetic mimetics enables dimer-selective Nurr1 modulationKatharina Scholz, Úrsula López-García, Romy Busch, et al.
Nature Communications|April 11, 2026
Structural optimization of drug molecules with incrementally trained language modelsTim Hörmann, Domenic Mayer, Max Lewandowski, et al.
Biochemical Pharmacology|May 27, 2019
A dual farnesoid X receptor/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in miceMd Abdul Hye Khan, Jurema Schmidt, Anna Stavniichuk, et al.
Journal of Medicinal Chemistry|October 23, 2025
Scaffold Fusion and SAR Transfer with a Chemical Language Model Generates Novel Liver X Receptor ModulatorsNils Christiaan Bandomir, Tim Hörmann, Annette Kärcher, et al.
Future Medicinal Chemistry|January 30, 2016
SAR studies on FXR modulators led to the discovery of the first combined FXR antagonistic/TGR5 agonistic compoundChristina Lamers, Daniel Merk, Matthias Gabler, et al.
International Journal of Molecular Sciences|September 9, 2022
Activity Screening of Fatty Acid Mimetic Drugs Identified Nuclear Receptor AgonistsMoritz Helmstädter, Simone Schierle, Laura Isigkeit, et al.
Frontiers in Immunology|January 18, 2024
Dual soluble epoxide hydrolase inhibitor - farnesoid X receptor agonist interventional treatment attenuates renal inflammation and fibrosisMd Abdul Hye Khan, Benjamin Nolan, Anna Stavniichuk, et al.
Communications Chemistry|January 27, 2023
The orphan nuclear receptor Nurr1 is responsive to non-steroidal anti-inflammatory drugsSabine Willems, Whitney Kilu, Xiaomin Ni, et al.
Journal of Medicinal Chemistry|July 21, 2020
Design and Structural Optimization of Dual FXR/PPARδ ActivatorsSimone Schierle, Sebastian Neumann, Pascal Heitel, et al.
International Journal of Molecular Sciences|November 14, 2020
Comprehensive Set of Tertiary Complex Structures and Palmitic Acid Binding Provide Molecular Insights into Ligand Design for RXR IsoformsApirat Chaikuad, Julius Pollinger, Michael Rühl, et al.
Pageof 17